Product Comparison


 
Medimmune 66019030710
Glaxo Smith Kline 19515090952
Medimmune 66019030510
Sanofi Pasteur 49281041850
McKesson # 1154804 1084580 1088857 1085679
Description FluMist® Quadrivalent 2020 - 2021 Flu Vaccine 10E6.5 - 7.5 FFU Indicated For People 2 to 49 Years of Age Intranasal Sprayer 0.2 mL Flulaval® Quadrivalent 2018 - 2019 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Prefilled Syringe 0.5 mL FluMist® Quadrivalent 2018 - 2019 Flu Vaccine 10E6.5 - 7.5 FFU Indicated For People 2 to 49 Years of Age Intranasal Sprayer 0.2 mL Fluzone® Quadrivalent 2018 - 2019 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Prefilled Syringe 0.5 mL
Manufacturer # 66019030710195150909526601903051049281041850
Brand FluMist® Quadrivalent 2020 - 2021Flulaval® Quadrivalent 2018 - 2019FluMist® Quadrivalent 2018 - 2019Fluzone® Quadrivalent 2018 - 2019
Manufacturer MedimmuneGlaxo Smith KlineMedimmuneSanofi Pasteur
Invoice FLUMIST QUAD 2020, SPR (10DOSE/BX)FLULAVAL QUAD 2018, SYR 0.5ML (10DOSE/BX)FLUMIST QUAD 2018, SPR (10DOSE/BX)FLUZONE 2018 QUAD, SYR 0.5ML (10DOSE/BX)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Container Type Intranasal SprayerPrefilled SyringeIntranasal SprayerPrefilled Syringe
Country of Origin UnknownUnknownUnknownUnited States
Dosage Form SprayInjectionSprayInjection
NDC Number 6601903071019515-0909-5266019-0305-1049281-0418-50
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 30 daysMcKesson Acceptable Dating: we will ship >= 14 daysMcKesson Acceptable Dating: we will ship >= 30 days
Strength 10E6.5 - 7.5 FFU60 mcg / 0.5 mL10E6.5 - 7.5 FFU60 mcg / 0.5 mL
Type IntranasalIntramuscularIntranasalIntramuscular
User Indicated For People 2 to 49 Years of AgeIndicated For People 6 Months of Age and AboveIndicated For People 2 to 49 Years of AgeIndicated For People 6 Months of Age and Above
Volume 0.2 mL0.5 mL0.2 mL0.5 mL
Application Flu VaccineFlu VaccineFlu VaccineFlu Vaccine
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
UNSPSC Code 51201608512016085120160851201608
Features and Benefits
  • FluMist®Quadrivalent (Influenza Vaccine Live, Intranasal) is a vaccine indicated for active immunization of persons 2-49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • FluMist®Quadrivalent is for intranasal administration only
  • FluMist Quadrivalent contains 4 influenza virus strains that are weakened (A(H1N1), A(H3N2), B Yamagata lineage, and B Victoria lineage)
  • FLULAVAL QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • FLULAVAL QUADRIVALENT is approved for use in persons 6 months of age and older
  • FLULAVAL QUADRIVALENT has been standardized according to USPHS requirements for the 2017-2018 influenza season and is formulated to contain 60 micrograms (mcg) hemagglutinin (HA) per 0.5-mL dose in the recommended ratio of 15 mcg HA of each of the following 4 viruses (2 A strains and 2 B strains): A/Singapore/GP1908/2015(H1N1) IVR 180 (an A/Michigan/45/2015 (H1N1) pdm09-like virus, A/Hong Kong/4801/2014 (H3N2) X-263B, B/Brisbane/60/2008 E530440, and B/Phuket/3073/2013
  • The prefilled syringe is formulated without preservatives and does not contain thimerosal
  • FluMist®Quadrivalent (Influenza Vaccine Live, Intranasal) is a vaccine indicated for active immunization of persons 2-49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • FluMist®Quadrivalent is for intranasal administration only
  • FluMist Quadrivalent contains four vaccine virus strains: an A/H1N1 strain, an A/H3N2 strain and two B strains
  • FluMist Quadrivalent contains 4 influenza virus strains that are weakened (A(H1N1), A(H3N2), B Yamagata lineage, and B Victoria lineage)
  • Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • Fluzone Quadrivalent is indicated for active immunization in persons 6 Months of age and older
  • Prefilled single-dose syringe (clear syringe plunger rod), 0.5 mL, for persons 36 months of age and older
  • Fluzone Quadrivalent (Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs
  • Fluzone Quadrivalent is standardized according to United States Public Health Service requirements and is formulated to contain HA of each of the following four influenza strains recommended for the 2017-2018 influenza season: A/Michigan/45/2015 X-275 (H1N1), A/Hong Kong/4801/2014 X-263B (H3N2), B/Phuket/3073/2013 (B Yamagata lineage), and B/Brisbane/60/2008 (B Victoria lineage)
  • The single-dose, pre-filled syringe (0.25 mL and 0.5 mL) and the single-dose vial (0.5 mL) are manufactured and formulated without thimerosal or any other preservative